Applehas been struggling for some time due to the ongoing patent dispute with medical device company Masimo. The reviews ended and the company faced an Apple Watch ban. For this reason Apple Watch Series 9 and Watch Ultra 2, It has been removed from the Apple store in the US. While things were not getting better for Apple, some good news came for them today.
Apple Watch import ban temporarily suspended
in Washington DC federal appeals court today ruled that Apple Watch Series 9 and Apple Watch Ultra 2 models to import He allowed it to continue. Court’s decision, Apple International Trade Commission It comes a day after the (ITC) appealed its decision banning imports of both models of the Apple Watch, which are at the center of the patent dispute.
Let us note that the court’s decision is temporary. The ITC was given until January 10 to respond to Apple’s request for a longer pause on the ban during the appeal process, Reuters reported. This means Apple should be able to continue selling the watches on its website and in Apple Stores in the US. However, at the moment, the watches are still not available for purchase in the Apple Online Store.
Apple’s smartwatch side generates approximately $17 billion in revenue annually. In October, the ITC determined that Apple had infringed two patents owned by Masimo, a California-based company. Both patents were related to the blood-oxygen sensor that Apple has included in most models of the Watch since 2020. The ITC rejected Apple’s appeal of the decision and sent the case to the White House for Presidential Review.
Apple Watch sales banned! The first statement came from the company
The decision to ban the sales of Apple Watch Series 9 and Ultra 2 came into force today. However, the company appealed this decision.
As a matter of fact, President Biden did not veto the ITC’s decision. This meant that the ban officially came into effect last week. In its objection on Tuesday, Apple said that if the ban continues, the company “will suffer irreparable damage” He claimed.
The company is currently looking at ways to redesign the blood oxygen sensors in its smartwatch after both ITC and Masimo agreed that a software fix the company initially tried to release would be insufficient to resolve the patent dispute.
So what do you think about this issue? You can share your thoughts with us in the comments section.